Instrument dashboard

ONEOK INC /NEW/ (OKE)

NYSE · US

OKE · Market chart

Loading chart…

Latest Pine script: 2026-11-20

Market structure

PRICE LEVEL INTELLIGENCE

Reference close · 2026-11-20
LEVEL / SOURCEPRICE LEVELPRICE
Inverse H&S NecklineTECHNICAL · Anchors: 2025-09-26 at 75.25 and 2025-12-05 at 76.85. x is elapsed 24-hour periods since 2025-09-26 09:30 America/New_York. The slope represents a 1.60 price increase over 70 calendar days. The inverse head-and-shoulders breakout close of 78.56 on 2026-01-22 exceeded the projected neckline of approximately 77.95. Latest close 86.52 remains above the projected neckline of approximately 84.83, so the line currently acts as support.
—
Rising Channel ResistanceTECHNICAL · Anchors: 2026-03-27 at 95.30 and 2026-09-08 at 97.83. x is elapsed 24-hour periods since 2026-03-27 09:30 America/New_York. The rising trajectory is supported by additional historical high interactions, including 96.07 on 2026-05-20 and 95.88 on 2026-07-24. The latest close 86.52 is below the projected boundary of approximately 98.93, making it resistance.
—
Rising Channel SupportTECHNICAL · Anchors: 2026-04-17 at 81.25 and 2026-11-06 at 85.04. x is elapsed 24-hour periods since 2026-04-17 09:30 America/New_York. Repeated historical low interactions support the trajectory, including 83.08 on 2026-06-18, 83.48 on 2026-08-04 and 84.15 on 2026-10-01. Latest close 86.52 is above the projected boundary of approximately 85.28, making it support.
—
ATR Support 67.03-70.41TECHNICAL · Boundaries derive from the 2025-10-29 control bar, with high 70.41 and low 67.03. True range 3.38 divided by Wilder ATR(14) approximately 1.66 gives 2.04 ATR. The upper boundary exactly aligns with the inverse head-and-shoulders right-shoulder low of 70.41 on 2026-01-08 and is close to the left-shoulder low of 70.63 on 2025-09-05. Latest close 86.52 is above the region, making it support.
67.03 – 70.41
ATR Support 75.47-83.85TECHNICAL · Boundaries derive from the 2025-04-07 control bar, with high 83.85 and low 75.47. True range 8.38 divided by Wilder ATR(14) approximately 3.96 gives 2.12 ATR. The region contains the 2025 annual pivot at 82.85 and the inverse head-and-shoulders neckline anchor at 76.85; its lower boundary is close to the other neckline anchor at 75.25. Latest close 86.52 is above the region, making it support.
75.47 – 83.85
ATR Resistance 92.02-95.12TECHNICAL · Boundaries derive from the 2026-11-02 control bar, with high 95.12 and low 92.02. True range 5.05 divided by Wilder ATR(14) approximately 2.49 gives 2.03 ATR. The region contains the October Traditional pivot at 92.96 and its upper boundary is close to Q3 R1 at 95.72. Latest close 86.52 is below the region, making it resistance.
92.02 – 95.12
ATR Resistance 108.87-117.55TECHNICAL · Boundaries derive from the 2024-11-25 control bar, with high 117.55 and low 108.87. True range 8.68 divided by Wilder ATR(14) approximately 2.78 gives 3.12 ATR. The upper boundary is 0.52 below the independently established historical maximum of 118.07 recorded on 2024-11-22. Latest close 86.52 is below the region, making it resistance.
108.87 – 117.55
Q3 S1TECHNICAL · Fixed Traditional S1 reference anchored to 2026-09-30. Conventional S1=2P-H using the supplied Q3 high and HLC/3 produces 79.22, rather than the script's 78.95; the exact calculation inputs are not established. Latest close 86.52 is above the level, making it support.
78.95
2025 Annual PTECHNICAL · Calculated from the completed 2025 trading year: high 111.02 on 2025-01-21, low 64.02 on 2025-11-04 and final close 73.50 on 2025-12-31. Traditional annual pivot=(H+L+C)/3=82.8467, rounded to 82.85. Latest close 86.52 is above the level, making it support.
82.85
Q3 PTECHNICAL · Fixed Traditional pivot reference anchored to 2026-09-30 in the script. The supplied Q3 OHLCV gives H=99.85, L=83.48 and C=85.27, producing conventional HLC/3=89.53 rather than 89.40. The exact inputs for the plotted value are not recoverable. Latest close 86.52 is below the level, making it resistance.
89.40
Inverse H&S Measured MoveTECHNICAL · Fixed measured-move objective encoded in the script at 91.8743, rounded to 91.87. It is associated with the inverse head-and-shoulders formation whose head is 64.02 and neckline anchors are 75.25 and 76.85. The script does not expose the precise projection arithmetic. Latest close 86.52 is below the objective, making it resistance.
91.87
October PTECHNICAL · Calculated from October 2026 high 97.65 on 2026-10-30, low 84.15 on 2026-10-01 and completed October close 97.07 on 2026-10-30. Traditional pivot=(H+L+C)/3=92.9567, rounded to 92.96. Latest close 86.52 is below the level, making it resistance.
92.96
Analyst 12-month low targetANALYST · Lowest analyst 12-month price target
93.00
Q3 R1TECHNICAL · Fixed Traditional R1 reference anchored to 2026-09-30. Using the supplied Q3 high and low with conventional HLC/3 produces R1=2P-L=95.59, rather than the script's 95.72; the exact calculation inputs are not established. Latest close 86.52 is below the level, making it resistance.
95.72
Analyst 12-month median targetANALYST · Median analyst 12-month price target
100.00
Analyst 12-month high targetANALYST · Highest analyst 12-month price target
115.00
All-Time HighTECHNICAL · Historical maximum recorded high of 118.07 on 2024-11-22. The script projects this fixed historical reference forward. Latest close 86.52 is below the level, making it resistance.
118.07
GEX put wall · 2026-12-18GEX · Options positioning
82.50
GEX call wall · 2026-12-18GEX · Options positioning
100.00

Sign in to view price levels

Technical, analyst and options-derived levels are available to signed-in members.

Sign in
AI-Ready Research Pack

Download the available financial metrics, calculation methodology and latest technical price levels for OKE.

Download research pack
Files included for this instrument:
  • SEC financial metrics calculation guide
  • Financial metrics for the current year
  • Technicals and future GEX levels
Company fundamentals

Financial health

Revenue••••••Profitability••••••Cash flow••••••Capital structure••••••
Available reporting years2026, 2025

Sign in to request beta access

Financial health insights are in a limited beta.

Sign in
Valuation framework

Valuation

Midpoint fair value••••••
Cash Flow DCF••••••
Revenue unit economics••••••
Reporting periods: 3 quarters available

Sign in to request beta access

Valuation tools are in a limited beta.

Sign in